118 related articles for article (PubMed ID: 36905268)
1. PAK5 is a potential target in myelodysplastic syndrome through interacting with LMO2 and GATA1.
Pan X; Liu D; Ying M; Zheng G; Fan C; Pan F; Ke Q
Cell Mol Biol (Noisy-le-grand); 2022 Sep; 68(9):77-85. PubMed ID: 36905268
[TBL] [Abstract][Full Text] [Related]
2. Structure of the leukemia oncogene LMO2: implications for the assembly of a hematopoietic transcription factor complex.
El Omari K; Hoosdally SJ; Tuladhar K; Karia D; Vyas P; Patient R; Porcher C; Mancini EJ
Blood; 2011 Feb; 117(7):2146-56. PubMed ID: 21076045
[TBL] [Abstract][Full Text] [Related]
3. Structural basis of simultaneous recruitment of the transcriptional regulators LMO2 and FOG1/ZFPM1 by the transcription factor GATA1.
Wilkinson-White L; Gamsjaeger R; Dastmalchi S; Wienert B; Stokes PH; Crossley M; Mackay JP; Matthews JM
Proc Natl Acad Sci U S A; 2011 Aug; 108(35):14443-8. PubMed ID: 21844373
[TBL] [Abstract][Full Text] [Related]
4. LMO2 Oncoprotein Stability in T-Cell Leukemia Requires Direct LDB1 Binding.
Layer JH; Alford CE; McDonald WH; Davé UP
Mol Cell Biol; 2016 Feb; 36(3):488-506. PubMed ID: 26598604
[TBL] [Abstract][Full Text] [Related]
5. Requirement for Lyl1 in a model of Lmo2-driven early T-cell precursor ALL.
McCormack MP; Shields BJ; Jackson JT; Nasa C; Shi W; Slater NJ; Tremblay CS; Rabbitts TH; Curtis DJ
Blood; 2013 Sep; 122(12):2093-103. PubMed ID: 23926305
[TBL] [Abstract][Full Text] [Related]
6. The Akt/mammalian target of rapamycin signal transduction pathway is activated in high-risk myelodysplastic syndromes and influences cell survival and proliferation.
Follo MY; Mongiorgi S; Bosi C; Cappellini A; Finelli C; Chiarini F; Papa V; Libra M; Martinelli G; Cocco L; Martelli AM
Cancer Res; 2007 May; 67(9):4287-94. PubMed ID: 17483341
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of Lhx2 suppresses proliferation of human T cell acute lymphoblastic leukemia-derived cells, partly by reducing LMO2 protein levels.
Miyashita K; Kitajima K; Goyama S; Kitamura T; Hara T
Biochem Biophys Res Commun; 2018 Jan; 495(3):2310-2316. PubMed ID: 29278703
[TBL] [Abstract][Full Text] [Related]
8. MiR-223 Suppresses Proliferation and Promotes Apoptosis of Diffuse Large B-Cell Lymphoma Cells Through Lmo2 and MAPK Signaling Pathway.
Zhang Y; Zhang J
J BUON; 2021; 26(2):580-586. PubMed ID: 34077008
[TBL] [Abstract][Full Text] [Related]
9. GATA1 induces epithelial-mesenchymal transition in breast cancer cells through PAK5 oncogenic signaling.
Li Y; Ke Q; Shao Y; Zhu G; Li Y; Geng N; Jin F; Li F
Oncotarget; 2015 Feb; 6(6):4345-56. PubMed ID: 25726523
[TBL] [Abstract][Full Text] [Related]
10. LMO2 attenuates tumor growth by targeting the Wnt signaling pathway in breast and colorectal cancer.
Liu Y; Huang D; Wang Z; Wu C; Zhang Z; Wang D; Li Z; Zhu T; Yang S; Sun W
Sci Rep; 2016 Oct; 6():36050. PubMed ID: 27779255
[TBL] [Abstract][Full Text] [Related]
11. PAK5-mediated phosphorylation and nuclear translocation of NF-κB-p65 promotes breast cancer cell proliferation in vitro and in vivo.
Zhang YC; Huo FC; Wei LL; Gong CC; Pan YJ; Mou J; Pei DS
J Exp Clin Cancer Res; 2017 Oct; 36(1):146. PubMed ID: 29041983
[TBL] [Abstract][Full Text] [Related]
12. Detection of LIM domain only 2 (LMO2) in normal human tissues and haematopoietic and non-haematopoietic tumours using a newly developed rabbit monoclonal antibody.
Agostinelli C; Paterson JC; Gupta R; Righi S; Sandri F; Piccaluga PP; Bacci F; Sabattini E; Pileri SA; Marafioti T
Histopathology; 2012 Jul; 61(1):33-46. PubMed ID: 22394247
[TBL] [Abstract][Full Text] [Related]
13. Enforced expression of E47 has differential effects on Lmo2-induced T-cell leukemias.
Goodings C; Tripathi R; Cleveland SM; Elliott N; Guo Y; Shyr Y; Davé UP
Leuk Res; 2015 Jan; 39(1):100-9. PubMed ID: 25499232
[TBL] [Abstract][Full Text] [Related]
14. PAK5 Induces EMT and Promotes Cell Migration and Invasion by Activating the PI3K/AKT Pathway in Ovarian Cancer.
Li D; Pan Y; Huang Y; Zhang P; Fang X
Anal Cell Pathol (Amst); 2018; 2018():8073124. PubMed ID: 30245957
[TBL] [Abstract][Full Text] [Related]
15. A DNA-binding mutant of TAL1 cooperates with LMO2 to cause T cell leukemia in mice.
Draheim KM; Hermance N; Yang Y; Arous E; Calvo J; Kelliher MA
Oncogene; 2011 Mar; 30(10):1252-60. PubMed ID: 21057528
[TBL] [Abstract][Full Text] [Related]
16. Prognostic impact of LIM domain only 2 (LMO2) in chronic myelogenous leukaemia.
Atay MH; Ozatli D; Kelkitli E; Yildiz L; Turgut M; Guler N; Toptas T
Histopathology; 2013 Aug; 63(2):293-4. PubMed ID: 23879574
[No Abstract] [Full Text] [Related]
17. PAK1 is a therapeutic target in acute myeloid leukemia and myelodysplastic syndrome.
Pandolfi A; Stanley RF; Yu Y; Bartholdy B; Pendurti G; Gritsman K; Boultwood J; Chernoff J; Verma A; Steidl U
Blood; 2015 Aug; 126(9):1118-27. PubMed ID: 26170031
[TBL] [Abstract][Full Text] [Related]
18. PAK5-mediated AIF phosphorylation inhibits its nuclear translocation and promotes breast cancer tumorigenesis.
Xing Y; Li Y; Hu B; Han F; Zhao X; Zhang H; Li Y; Li D; Li J; Jin F; Li F
Int J Biol Sci; 2021; 17(5):1315-1327. PubMed ID: 33867848
[TBL] [Abstract][Full Text] [Related]
19. Expression of the leukemia oncogene Lmo2 is controlled by an array of tissue-specific elements dispersed over 100 kb and bound by Tal1/Lmo2, Ets, and Gata factors.
Landry JR; Bonadies N; Kinston S; Knezevic K; Wilson NK; Oram SH; Janes M; Piltz S; Hammett M; Carter J; Hamilton T; Donaldson IJ; Lacaud G; Frampton J; Follows G; Kouskoff V; Göttgens B
Blood; 2009 Jun; 113(23):5783-92. PubMed ID: 19171877
[TBL] [Abstract][Full Text] [Related]
20. p21-Activated kinase 5 (Pak5) localizes to mitochondria and inhibits apoptosis by phosphorylating BAD.
Cotteret S; Jaffer ZM; Beeser A; Chernoff J
Mol Cell Biol; 2003 Aug; 23(16):5526-39. PubMed ID: 12897128
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
